Literature DB >> 16170608

Antifungal susceptibility and pathogenic potential of environmental isolated filamentous fungi compared with colonizing agents in immunocompromised patients.

A B A Teixeira1, M Silva, L Lyra, E A Luz, J Uno, H Takada, M Miyaji, K Nishimura, A Z Schreiber.   

Abstract

Infection is a major cause of morbidity and mortality in bone marrow transplant recipients and in patients with hematological malignancies. The source of infection is almost always endogenous flora or the hospital environment. The present study evaluated bone marrow transplant recipients and patients with hematological malignancies colonized and/or infected with filamentous fungi. During 1 year, environmental air samples were also taken from the bone marrow transplant unit by a modification of gravity air-setting plate (GASP) methodology. Fusarium spp. were the most prevalent genus in the fall and Cladosporium spp. in the winter. Clinically isolated strains grew better at 37 degrees C than environmental strains. According to NCCLS M-38P methods, environmental Aspergillus strains showed higher MICs to miconazol and itraconazol, and clinical Fusarium strains were less susceptible to fluconazole.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16170608     DOI: 10.1007/s11046-005-0117-z

Source DB:  PubMed          Journal:  Mycopathologia        ISSN: 0301-486X            Impact factor:   2.574


  17 in total

1.  DNA fingerprinting of Fusarium solani isolates related to a cutaneous infection in a sea turtle.

Authors:  G Castellá; J Cano; J Guarro; F J Cabañes
Journal:  Med Mycol       Date:  1999-08       Impact factor: 4.076

Review 2.  In vitro antifungal susceptibility testing and measurement of levels of antifungal agents in body fluids.

Authors:  D J Drutz
Journal:  Rev Infect Dis       Date:  1987 Mar-Apr

3.  Genetic diversity among clinical and environmental isolates of Aspergillus fumigatus.

Authors:  J P Debeaupuis; J Sarfati; V Chazalet; J P Latgé
Journal:  Infect Immun       Date:  1997-08       Impact factor: 3.441

4.  In-vitro antifungal susceptibility of clinical and environmental Fusarium spp. strains.

Authors:  I Pujol; J Guarro; J Gené; J Sala
Journal:  J Antimicrob Chemother       Date:  1997-02       Impact factor: 5.790

5.  Phaeohyphomycosis caused by Chaetomium globosum in an allogeneic bone marrow transplant recipient.

Authors:  A B A Teixeira; P Trabasso; M L Moretti-Branchini; F H Aoki; A C Vigorito; M Miyaji; Y Mikami; M Takada; A Z Schreiber
Journal:  Mycopathologia       Date:  2003       Impact factor: 2.574

Review 6.  Antimicrobial prophylaxis in bone marrow transplantation.

Authors:  F Momin; P H Chandrasekar
Journal:  Ann Intern Med       Date:  1995-08-01       Impact factor: 25.391

7.  Molecular typing of environmental and patient isolates of Aspergillus fumigatus from various hospital settings.

Authors:  V Chazalet; J P Debeaupuis; J Sarfati; J Lortholary; P Ribaud; P Shah; M Cornet; H Vu Thien; E Gluckman; G Brücker; J P Latgé
Journal:  J Clin Microbiol       Date:  1998-06       Impact factor: 5.948

8.  Fusarium fungaemia in immunocompromised patients.

Authors:  T G Jensen; B Gahrn-Hansen; M Arendrup; B Bruun
Journal:  Clin Microbiol Infect       Date:  2004-06       Impact factor: 8.067

9.  In-vitro activities of amphotericin B, itraconazole and voriconazole against 150 clinical and environmental Aspergillus fumigatus isolates.

Authors:  P E Verweij; M Mensink; A J Rijs; J P Donnelly; J F Meis; D W Denning
Journal:  J Antimicrob Chemother       Date:  1998-09       Impact factor: 5.790

10.  Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation--a prospective, randomized, double-blind study.

Authors:  M A Slavin; B Osborne; R Adams; M J Levenstein; H G Schoch; A R Feldman; J D Meyers; R A Bowden
Journal:  J Infect Dis       Date:  1995-06       Impact factor: 5.226

View more
  3 in total

Review 1.  Updating corneofungimetry: a bioassay exploring dermatomycoses and antifungal susceptibility.

Authors:  Gérald E Piérard; Claudine Piérard-Franchimont; Pascale Quatresooz
Journal:  Mycopathologia       Date:  2010-01       Impact factor: 2.574

2.  Update on the treatment of disseminated fusariosis: Focus on voriconazole.

Authors:  Marta Stanzani; Fabio Tumietto; Nicola Vianelli; Michele Baccarani
Journal:  Ther Clin Risk Manag       Date:  2007-12       Impact factor: 2.423

3.  Disseminated Fusarium infection in autologous stem cell transplant recipient.

Authors:  Vivian Iida Avelino-Silva; Jessica Fernandes Ramos; Fabio Eudes Leal; Leonardo Testagrossa; Yana Sarkis Novis
Journal:  Braz J Infect Dis       Date:  2014-10-13       Impact factor: 3.257

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.